Who is sponsoring NCT05985031?

NCT05985031 is sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital.

What condition does NCT05985031 study?

NCT05985031 studies Spinal Cord Injuries.

What drugs are being tested in NCT05985031?

Interventions: Tendon tap, Tibial nerve stimulation.

What is the status of NCT05985031?

NCT05985031 is currently COMPLETED.

Last reviewed 2023-08-15 · How we verify

Reciprocal Inhibition Versus Reciprocal Facilitation In Spinal Cord Injury Patients

NCT05985031 NA COMPLETED

Reciprocal inhibition is a medulla spinalis control mechanism that facilitates motor activities in healthy people. As the agonist muscle contracts, the antagonist muscle is inhibited so that the agonist action can take place properly. In the literature, there are studies showing that in patients with upper motor neuron lesions, this reverses, and reciprocal facilitation occurs instead of inhibition. However, there is no clear situation in this regard, there is a need for more methodologically sound studies. Our aim in this study is to investigate the presence of reciprocal facilitation in patients with spinal cord lesions (SCL).

Details

Lead sponsor	Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Phase	NA
Status	COMPLETED
Enrolment	10
Start date	Thu Jan 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Spinal Cord Injuries

Interventions

Tendon tap
Tibial nerve stimulation

Countries

Turkey (Türkiye)